Phase II trial of linifanib in patients (pts) with advanced renal cell carcinoma (RCC): Analysis of pts receiving extended therapy.
E. M. Posadas
No relevant relationships to disclose
N. M. Tannir
Research Funding - Abbott Laboratories
Y. Wong
No relevant relationships to disclose
M. S. Ernstoff
Stock Ownership - Abbott Laboratories (I)
C. K. Kollmannsberger
No relevant relationships to disclose
J. Qian
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
P. J. Ansell
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
E. M. McKeegan
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
M. D. McKee
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
J. L. Ricker
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
D. M. Carlson
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
M. D. Michaelson
Consultant or Advisory Role - Abbott Laboratories (U); AVEO (U); Genentech (U); Novartis (U); Pfizer (U); Wyeth (U)
Research Funding - Abbott Laboratories; Bayer; Genentech; GlaxoSmithKline; Novartis; Pfizer; Wyeth